Ascentage Pharma Group International 6855

Updated: 16 Jun 2026

HKEX | Biotech | Biotechnology, oncology therapeutics

No signal published yet

We already track Ascentage Pharma Group International and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Ascentage Pharma Group International free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
HKEX
Type
Biotech
Sector
Biotechnology, oncology therapeutics
We're already tracking Ascentage Pharma Group International — here are the latest events we've registered

Recent News

  • In June 2026, Ascentage Pharma presented updated clinical data for its lead candidate olverembatinib at the ASCO Annual Meeting. The data demonstrated sustained therapeutic efficacy and a manageable safety profile in patients with resistant chronic myeloid leukemia.

What Firelda Watch includes for Ascentage Pharma Group International

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Ascentage Pharma Group International will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Hansa Biopharma AB (publ)
HNSA
HOLD
Bioarctic
BIOA B
BUY
Sprint Bioscience AB (publ)
SPRINT
NEUTRAL
Xbrane Biopharma AB (publ)
XBRANE
HOLD
SynAct Pharma AB
SYNACT
HOLD

Biotech

More companies in this sector

Want to follow Ascentage Pharma Group International? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Ascentage Pharma Group International free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Ascentage Pharma Group International 6855
Ascentage Pharma Group International — follow and we'll monitor it
Follow Ascentage Pharma Group International free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.